Skip to main content
Premium Trial:

Request an Annual Quote

Predicting Problems: Genetic Markers Show Whether Antidepressants Might Backfire

Since the FDA slapped black-box warnings in 2005 on certain antidepressants associated with triggering suicidal thinking in kids and teenagers, scientists have been trying to figure out if there's genetic susceptibility for that. Two recent studies have come out, one led by Francis McMahon at the NIMH and the other by Roy Perlis at Harvard, implicating markers on three separate genes that might influence suicidal thinking for those taking the common SSRI citalopram, sold under the brand name Celexa.

The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.